SCHWAZZE ENDS 2022 STRONG WITH ADDITIONAL CANNABIS DISPENSARY OPENING IN NEW MEXICO, BRINGING R.GREENLEAF DISPENSARY STORE COUNT TO 16
Jan. 3, 2023
(OTCQX: SHWZ) (NEO: SHWZ)
a premier vertically integrated, multi-state operating cannabis company with assets in
, announces the grand opening of its adult-use dispensary,
, located in
Alamogordo, New Mexico
. The new store, located at 101 N. White Sands Blvd in
, officially opened its doors for business on
December 29, 2022
. Store operating hours are 9a to 9p Monday through Saturday; 9a to 8p on Sunday.
The Alamogordo R.Greenleaf store opening continues the intentional expansion throughout the state of
and comes on the heels of a total of five R.Greenleaf store openings since Schwazze’s acquisition in
. This brings R.Greenleaf’s total number of
retail dispensaries to 16. All locations serve the needs of medical patients as well as recreational adult-use consumers.
“We are excited to open up our sixth R.Greenleaf dispensary since late September, this one specifically in
. The team has been hard at work to get this completed in time for the holiday season to serve this local community,” said
, New Mexico Division President for Schwazze. “R.Greenleaf, offering a wide variety of quality products serviced by top-notch, knowledgeable staff, has grown from 10 locations to now 16 in
since Schwazze purchased the retail banner earlier this year.”
R.Greenleaf Alamogordo will also offer introductory pricing on flower, edibles, and vapes. Enrollment in the Gratify Rewards customer loyalty program, which can be used at any Schwazze-owned retail dispensary in either
, is already open.
Alamogordo Store Location
101 N. White Sands Blvd
, Schwazze has acquired, opened or announced the planned acquisition of 41 cannabis retail dispensaries as well as seven cultivation facilities and two manufacturing plants in
, Schwazze announced its Biosciences division and in
it commenced home delivery services in
Schwazze (OTCQX: SHWZ NEO: SHWZ) is building a premier vertically integrated regional cannabis company with assets in
and will continue to take its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector. Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices.
Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth.
This press release contains “forward-looking statements.” Such statements may be preceded by the words “plan,” “will,” “may,” “continue,” “predicts,” or similar words. Forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; (v) difficulties in securing regulatory approval to market our products and product candidates; (vi) our ability to successfully execute our growth strategy in
and outside the state, (vii) our ability to consummate the acquisition described in this press release or to identify and consummate future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses, including the acquisition described in this press release, and realize synergies therefrom, (ix) the ongoing COVID-19 pandemic, * the timing and extent of governmental stimulus programs, and (xi) the uncertainty in the application of federal, state and local laws to our business, and any changes in such laws. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at
. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.
View original content to download multimedia:
View original content to download multimedia:
Featured image: Megapixl © Viennetta